ReShape Lifesciences, Inc. (HIND)
Market Closed
15 Oct, 08:00 PM
NASDAQ (NMS) NASDAQ (NMS) Primary $
1. 91
-0.02
-1.0363%
$
13.41M Market Cap
- P/E Ratio
- Div Yield
15,000 Volume
- Eps
$ 1.93
Previous Close 
Want to track HIND and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
ReShape Lifesciences, Inc. (HIND) Statistics
Valuation metrics
Market Cap 13.41M
Enterprise value 6.8M
Trailing P/E (ttm) -0.07
Forward P/E -
PEG ratio -0
Price/Sales (ttm) 113.08
Price/Book (mrq) 2.43
Enterprise Value/Revenue 52.41
Enterprise Value/EBITDA -0.59
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 7.55K
Average volume (90 days) 6.12K
Price summary
52-Week low 1.75
52-Week high 6.56
Beta -
50-Day moving average 2.08
200-Day moving average 2.15
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:4
Last split Date 15 Aug 2025
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -87.17%
Operating margin -32.5%
Operational effectiveness
Return on assets -1.23%
Return on equity -2.55%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.02
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.61
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 1.12
Total debt (mrq) -
Total Debt/Equity (mrq) 0
Current ratio (mrq) 4.37%
Book value per share (mrq) 1.04
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
